# QuidelOrtho Corporation (QDEL) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $13.97, market value $958 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). QuidelOrtho Corporation reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **PEG: 0.21**. A PEG of 0.21 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 0.4×**. Each dollar of revenue is priced at 0.4×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 0.5×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **Free-cash-flow yield: -22.0%** (5-yr avg 3.5%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Operating margin: -30.8%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -41.5%**. The company reported a net loss over the last twelve months.
- **Return on equity: -58.9%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -14.1%**. Return on all capital, debt included, is -14.1%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -18.2%**. Each dollar of assets produces -18.2% of profit.

## Growth
- **Revenue growth (1 yr): -1.9%** (3-yr -5.8%/yr, 5-yr 10.4%/yr). Revenue fell 1.9% over the last year, against 10.4% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 45.4%**. Earnings per share rose 45.4%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 1.50**. Debt is 1.50 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Net debt / EBITDA: net cash**. QuidelOrtho Corporation holds more cash than debt.
- **Altman Z-score: 0.56**. A Z-score of 0.56 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. QuidelOrtho Corporation does not currently pay a dividend.

## Analyst view
- **Analyst consensus: hold** (3 analysts). 3 analysts cover QuidelOrtho Corporation; the consensus is hold, with an average price target of $14.67 (+5% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -49.7%** (YTD -51.1%, 3-mo -2.5%). The shares are down 49.7% over twelve months including dividends.
- **From 52-week high: -60.7%** (40.8% above the low). Trading 61% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 43**. An RSI of 43 is neutral.
- **Beta (1 yr): 2.38** (volatility 89%). Beta of 2.38 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=QDEL · Page: https://foliofundamentals.com/stocks/qdel

Not investment advice.